Skip to content

Surgi-Vision Urethral Coil

by Surgi-Vision, Inc.

510(k) K002345

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK002345 Date11 Oct 2000ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
MOS
Device Class
Class II
Regulation
21 CFR Part 892.1000
Advisory Committee
Radiology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Surgi-Vision Urethral Coil is a Coil, Magnetic Resonance, Specialty device designed for use in radiology. It is intended for imaging applications within MRI systems, facilitating high-resolution visualization of anatomical structures in the urethral region.

This device is supplied as a reusable medical instrument and is classified as Class II under FDA regulations (892.1000). It is intended for use in MRI environments, with specific FEI numbers listed for compatibility. The device received FDA 510K clearance under K-number K002345 in 2000, with a decision of Substantially Equivalent to a predicate device. No third-party review was required.

Other devices from Surgivision, Inc.

See all devices from Surgivision, Inc. →

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the primary purpose of the Surgi-Vision Urethral Coil in a clinical setting?

    The Surgi-Vision Urethral Coil is specifically designed for use in MRI systems to enhance imaging of anatomical structures in the urethral region. It aids radiologists in achieving high-resolution visualization during MRI scans, ensuring clearer diagnostic images for evaluation.

  • Is the Surgi-Vision Urethral Coil intended for single-use or reusable applications?

    The device is explicitly supplied as a reusable medical instrument, meaning it is engineered for repeated use in MRI environments after proper cleaning, sterilization, and maintenance. This aligns with its classification as a Class II reusable device under FDA regulations.

  • How do I verify compatibility of the Surgi-Vision Urethral Coil with my MRI system?

    Compatibility is confirmed through the device’s FEI numbers, which are unique identifiers for MRI safety and performance. The coil is listed with multiple FEI numbers (e.g., 3009529630, 3027339477, etc.), ensuring it meets the specific requirements of various MRI systems. Always cross-reference your system’s FEI number with the provided list to ensure proper use.

  • What regulatory pathway was followed for FDA clearance of the Surgi-Vision Urethral Coil?

    The device received FDA clearance through a 510(k) premarket notification process under K-number K002345, filed in 2000. The decision was based on a determination of substantial equivalence to a predicate device, with no third-party review required. The clearance was granted under the Radiology advisory committee (RA) and classified under product code MOS (Magnetic Resonance, Specialty).

  • Where can I find additional details about the manufacturer or contact information for support?

    For manufacturer details, the Surgi-Vision Urethral Coil is produced by Surgi-Vision, Inc., headquartered at 9250 Rumsey Rd., Suite 100, Columbia, MD 21045. For inquiries or support, you may contact Nancy E. Taylor, though direct contact methods (e.g., phone/email) are not provided in the regulatory data. Always verify current contact information through official channels.